# Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer

> **NCT01065441** · PHASE1,PHASE2 · COMPLETED · sponsor: **Michael Har-Noy** · enrollment: 9 (actual)

## Conditions studied

- Solid Tumors Stage II, Stage III and Stage IV
- Breast Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma
- Ovarian Cancer
- Sarcoma
- Non-small Cell Lung Cancer

## Interventions

- **BIOLOGICAL:** AlloStim
- **PROCEDURE:** Cryoablation
- **BIOLOGICAL:** AlloStim
- **BIOLOGICAL:** AlloStim
- **BIOLOGICAL:** AlloStim
- **BIOLOGICAL:** AlloStim
- **BIOLOGICAL:** AlloStim

## Key facts

- **NCT ID:** NCT01065441
- **Lead sponsor:** Michael Har-Noy
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2013-07
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2020-01-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01065441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01065441, "Experimental Therapeutic Cancer Vaccine Created In-situ in Patients With Stage II-Stage IV Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT01065441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*